Indian Journal of Pharmacology Home 

SHORT COMMUNICATION
[Download PDF]
Year : 1995  |  Volume : 27  |  Issue : 3  |  Page : 183--185

Rifampicin pretreatment reduces bioavailability of diclofenac sodium

Kumar J Surya1, Mamidi NVS Rao2, T Chakrapani3, DR Krishna4 
1 
2 
3 
4 

Correspondence Address:
Kumar J Surya


Diclofenac sodium 100 mg (2 x 50 mg enteric coated tablets) alone and in combination with rifampicin 600 mg as a single dose (group I and group II respectively) was administered to six healthy human volunteers in a cross over design. In the second study diclofenac sodium 100 mg was administered after a six day treatment with rifampicin 450 mg daily (Group Ill). Plasma concentrations of diclofenac were determined during a 8 hour period following drug administration. The mean peak plasma concentrations (Cmax) were 5.28, 6.68 and 2.99 fig/ml, time taken to reach. the peak (Tmax) were 3.17, 3.25 and 2.5 hrs and area under curve[AUC(0-()] were 14.17, 13.74 and 4.63 ug.hr/ml in the groups I, II and Ill respectively. Statistically a significant difference was observed in Cmax , AUC(0-() (P < 0.01) and Cl/f (P < 0.05) of diclofenac sodium when administered after six days treatment with rifampicin. However, there was no difference in pharmacokinetic parameters when diclofenac was administered with rifampicin as a single dose.


How to cite this article:
Surya KJ, Rao MN, Chakrapani T, Krishna D R. Rifampicin pretreatment reduces bioavailability of diclofenac sodium.Indian J Pharmacol 1995;27:183-185


How to cite this URL:
Surya KJ, Rao MN, Chakrapani T, Krishna D R. Rifampicin pretreatment reduces bioavailability of diclofenac sodium. Indian J Pharmacol [serial online] 1995 [cited 2020 Sep 21 ];27:183-185
Available from: http://www.ijp-online.com/article.asp?issn=0253-7613;year=1995;volume=27;issue=3;spage=183;epage=185;aulast=Surya;type=0